These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 477314)

  • 21. Epidemiology of endometriosis in women attending family planning clinics.
    Vessey MP; Villard-Mackintosh L; Painter R
    BMJ; 1993 Jan; 306(6871):182-4. PubMed ID: 8338516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Canadian Contraception Consensus (Part 3 of 4): Chapter 7--Intrauterine Contraception.
    Black A; Guilbert E; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman W; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; Mansouri S
    J Obstet Gynaecol Can; 2016 Feb; 38(2):182-222. PubMed ID: 27032746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Iron status in Danish women aged 35-65 years. Relation to menstruation and method of contraception.
    Milman N; Rosdahl N; Lyhne N; Jørgensen T; Graudal N
    Acta Obstet Gynecol Scand; 1993 Nov; 72(8):601-5. PubMed ID: 8259744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Iron status in 268 Danish women aged 18-30 years: influence of menstruation, contraceptive method, and iron supplementation.
    Milman N; Clausen J; Byg KE
    Ann Hematol; 1998; 77(1-2):13-9. PubMed ID: 9760147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acceptability study of the two versus three monthly injectable contraceptives.
    Aly FA; El-genedi MM; Toppozada HK; El-abd M; Loutfi I
    Dirasat Sukkaniyah; 1984; 11(69):27-39. PubMed ID: 12179796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two years' experience with two levonorgestrel-releasing intrauterine devices and one copper-releasing intrauterine device: a randomized comparative performance study.
    Nilsson CG; Allonen H; Diaz J; Luukkainen T
    Fertil Steril; 1983 Feb; 39(2):187-92. PubMed ID: 6401636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A longitudinal study of contraception and pregnancy outcome in a representative sample of young Swedish women.
    Milsom I; Sundell G; Andersch B
    Contraception; 1991 Feb; 43(2):111-9. PubMed ID: 2040167
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use-effectiveness of oral and intrauterine contraception.
    Tietze C; Lewitt S
    Fertil Steril; 1971 Aug; 22(8):508-13. PubMed ID: 5110233
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The influence of a low-dose combined oral contraceptive on menstrual blood loss and iron status.
    Larsson G; Milsom I; Lindstedt G; Rybo G
    Contraception; 1992 Oct; 46(4):327-34. PubMed ID: 1486771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Menstrual flow duration and spotting following Multiload Copper 250 intra-uterine device insertion.
    Goh TH; Ang ES; Yip YC
    J Obstet Gynaecol (Lahore); 1983 Oct; 4(2):127-8. PubMed ID: 12279948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Menstrual blood loss of TCu-380 A and TCu-200 B IUDs.
    El-sheikha Z; Hamza A; Mahmoud M
    Popul Sci; 1990 Jul; ():55-62. PubMed ID: 12343358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduced menstrual blood loss by release of an antifibrinolytic agent from intrauterine contraceptive devices.
    Tauber PF; Kloppel A; Goodpasture JC; Burns J; Ludwig H; Zaneveld LJ
    Am J Obstet Gynecol; 1981 Jun; 140(3):322-8. PubMed ID: 7246636
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Menstrual blood loss during oral contraceptive therapy and in IUD users.
    Hefnawi F; Younis N; Zaki K; Rassik SA; Mekkawi T
    Egypt Popul Fam Plann Rev; 1970 Jun; 3(1):1-4. PubMed ID: 12254505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contraception after thirty-five.
    Luukkainen T
    Acta Obstet Gynecol Scand; 1992 Apr; 71(3):169-74. PubMed ID: 1317637
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intrauterine contraceptive devices. Complications associated with their use.
    Nagel TC
    Postgrad Med; 1983 Mar; 73(3):155-64. PubMed ID: 6828391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The menstrual cycle in women using an intrauterine device.
    Faundes A; Segal SJ; Adejuwon CA; Brache V; Leon P; Alvarez-Sanchez F
    Fertil Steril; 1980 Nov; 34(5):427-30. PubMed ID: 7439408
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pregnancy-specific beta 1-glycoprotein and chorionic gonadotropin-like immunoreactivity during the latter half of the cycle in women using intrauterine contraception.
    Seppälä M; Rutanen EM; Jalanko H; Lehtovirta P; Stenman UH; Engvall E
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1216-9. PubMed ID: 318094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of contraceptive agents on the biochemical and protein composition of human endometrium.
    Umapathysivam K; Jones WR
    Contraception; 1980 Oct; 22(4):425-40. PubMed ID: 6160951
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rates and outcomes of planned pregnancy after use of Norplant capsules, Norplant II rods, or levonorgestrel-releasing or copper TCu 380Ag intrauterine contraceptive devices.
    Sivin I; Stern J; Diaz S; Pavéz M; Alvarez F; Brache V; Mishell DR; Lacarra M; McCarthy T; Holma P
    Am J Obstet Gynecol; 1992 Apr; 166(4):1208-13. PubMed ID: 1566771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of three different models of the copper T intrauterine contraceptive device.
    Roy S; Casagrande J; Cooper DL; Mishell DR
    Am J Obstet Gynecol; 1979 Jul; 134(5):568-74. PubMed ID: 453297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.